These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 24513149

  • 1. The history of haemophilia - a short review.
    Schramm W.
    Thromb Res; 2014 Nov; 134 Suppl 1():S4-9. PubMed ID: 24513149
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Twenty years of treatment with Beriate® P.
    Brackmann HH.
    Thromb Res; 2014 Nov; 134 Suppl 1():S1-3. PubMed ID: 24360930
    [No Abstract] [Full Text] [Related]

  • 5. Long-term efficacy and safety of a pasteurized, plasma-derived factor VIII concentrate (Beriate® P) in patients with haemophilia A.
    Klamroth R, Gottstein S, Orlovic M, Heinrichs C.
    Thromb Res; 2014 Nov; 134 Suppl 1():S38-42. PubMed ID: 24256767
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Legal requirements for optimal haemophilia treatment in Germany.
    Brackmann HH.
    Thromb Res; 2014 Nov; 134 Suppl 1():S68-71. PubMed ID: 24360933
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive care for hemophilia and other inherited bleeding disorders.
    Page D.
    Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
    [Abstract] [Full Text] [Related]

  • 9. Challenges for new haemophilia products from a manufacturer's perspective.
    Schulte S.
    Thromb Res; 2014 Nov; 134 Suppl 1():S72-6. PubMed ID: 24360931
    [Abstract] [Full Text] [Related]

  • 10. The need for recombinant factor VIII: historical background and rationale.
    Hilgartner MW.
    Semin Hematol; 1991 Apr; 28(2 Suppl 1):6-9. PubMed ID: 1908132
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changing paradigm of prophylaxis with longer acting factor concentrates.
    Carcao M.
    Haemophilia; 2014 May; 20 Suppl 4():99-105. PubMed ID: 24762284
    [Abstract] [Full Text] [Related]

  • 15. History of haemophilia.
    Aledort LM.
    Haemophilia; 2007 Dec; 13 Suppl 5():1-2. PubMed ID: 18240391
    [Abstract] [Full Text] [Related]

  • 16. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E, Mauser-Bunschoten EP.
    Ned Tijdschr Geneeskd; 1997 Dec 27; 141(52):2566-71. PubMed ID: 9555158
    [Abstract] [Full Text] [Related]

  • 17. Haemophilia, the journey in search of a cure. 1960-2020.
    Nathwani AC, Tuddenham EGD.
    Br J Haematol; 2020 Nov 27; 191(4):573-578. PubMed ID: 33190257
    [Abstract] [Full Text] [Related]

  • 18. An adventure in biotechnology: the development of haemophilia A therapeutics -- from whole-blood transfusion to recombinant DNA to gene therapy.
    Kingdon HS, Lundblad RL.
    Biotechnol Appl Biochem; 2002 Apr 27; 35(2):141-8. PubMed ID: 11916456
    [Abstract] [Full Text] [Related]

  • 19. Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.
    Rothschild C, D'Oiron R, Borel-Derlon A, Gruel Y, Navarro R, Negrier C.
    Haemophilia; 2013 Mar 27; 19(2):281-6. PubMed ID: 23038998
    [Abstract] [Full Text] [Related]

  • 20. Why should we care about quality of life in persons with haemophilia?
    Aledort L, Bullinger M, von Mackensen S, Wasserman J, Young NL, Globe D, Health Related Quality of Life Expert Working Group of the International Prophylaxis Study Group.
    Haemophilia; 2012 May 27; 18(3):e154-7. PubMed ID: 22356125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.